Tumor-infiltrating B cells evolve towards interferon-rich trajectories aligned with immunotherapy in melanoma.
- DOI
- 10.1186/s13046-026-03797-1
- Published
- 2026 Aug 7
- Container
- Journal of experimental & clinical cancer research : CR
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13046-026-03797-1,
title = {Tumor-infiltrating B cells evolve towards interferon-rich trajectories aligned with immunotherapy in melanoma.},
author = {Stoker K and Laddach R and Booth L and Crescioli S and Maiques O and Adams R and Chauhan J and Stewart A and Patel D and Fitzpatrick A and Wu Y and Geh JLC and Salem O and MacKenzie Ross AD and Lloyd-Hughes H and Whittaker S and Ng J and Fraternali F and Kipling D and Dunn-Walters DK and Lacy KE and Tull TJ and Tsoka S and Karagiannis SN},
year = {2026},
journal = {Journal of experimental \& clinical cancer research : CR},
doi = {10.1186/s13046-026-03797-1},
url = {https://doi.org/10.1186/s13046-026-03797-1}
}RIS
TY - JOUR TI - Tumor-infiltrating B cells evolve towards interferon-rich trajectories aligned with immunotherapy in melanoma. AU - Stoker K AU - Laddach R AU - Booth L AU - Crescioli S AU - Maiques O AU - Adams R AU - Chauhan J AU - Stewart A AU - Patel D AU - Fitzpatrick A AU - Wu Y AU - Geh JLC AU - Salem O AU - MacKenzie Ross AD AU - Lloyd-Hughes H AU - Whittaker S AU - Ng J AU - Fraternali F AU - Kipling D AU - Dunn-Walters DK AU - Lacy KE AU - Tull TJ AU - Tsoka S AU - Karagiannis SN PY - 2026 JO - Journal of experimental & clinical cancer research : CR DO - 10.1186/s13046-026-03797-1 UR - https://doi.org/10.1186/s13046-026-03797-1 ER -
APA
K, S., R, L., L, B., S, C., O, M., R, A., J, C., A, S., D, P., A, F., Y, W., JLC, G., O, S., AD, M. R., H, L., S, W., J, N., F, F., D, K., DK, D., KE, L., TJ, T., S, T., & SN, K. (2026). Tumor-infiltrating B cells evolve towards interferon-rich trajectories aligned with immunotherapy in melanoma.. Journal of experimental & clinical cancer research : CR. https://doi.org/10.1186/s13046-026-03797-1
Source records
- pubmed · retrieved 2026-09-25T20:08:28.852Z